WallStreetZenWallStreetZen

NYSE: DLB
Dolby Laboratories Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Dolby Laboratories earnings were $256.6M for the trailing 12 months ending Mar 28, 2025, with 34.2% growth year over year. The latest DLB earnings report on Mar 28, 2025 announced Q1 2025 earnings of $91.8M, up 35.3% from last quarter. For the last reported fiscal year 2024 ending Sep 27, 2024, DLB reported annual earnings of $261.8M, with 30.5% growth.

DLB past earnings growth

How has DLB's earnings growth performed historically?

Company
34.17%
Industry
6.08%
Market
34%
DLB's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DLB's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DLB's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DLB earnings history

Current Revenue
$1.3B
Current Earnings
$256.6M
Current Profit Margin
19.4%
DLB's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

DLB Return on Equity

Current Company
10.3%
Current Industry
21.7%
Current Market
31.5%
DLB's Return on Equity (10.3%)... subscribe to Premium to read more.
High Return on Equity Performance

DLB undefined

Current Company
8.2%
Current Industry
12.4%
DLB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DLB announces earnings.

DLB undefined

Current Company
10.52%
Current Industry
17.7%
DLB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DLB vs Specialty Business Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DLB$386.73M$256.63M+3.95%$2.67
MMS$621.86M$300.02M+9.26%$5.06
CBZ$245.11M$86.93M-2.25%$1.16
ARMK$1.25B$348.01M+22.94%$1.32
FA$123.34M-$148.56MN/A-$0.96
View Top Specialty Business Service Stocks

Dolby Laboratories Earnings Reports & History FAQ

What were Dolby Laboratories's earnings last quarter?

On DLB's earnings call on Invalid Date, Dolby Laboratories (NYSE: DLB) reported Q1 2025 earnings per share (EPS) of $0.95, up 6.86% year over year. Total DLB earnings for the quarter were $91.79 million. In the same quarter last year, Dolby Laboratories's earnings per share (EPS) was $1.02.

If you're new to stock investing, here's how to buy Dolby Laboratories stock.

Is Dolby Laboratories profitable or losing money?

As of the last Dolby Laboratories earnings report, Dolby Laboratories is currently profitable. Dolby Laboratories's net profit (also called net income) for the twelve months ending Mar 28, 2025 was $256.63 million, a 34.79% increase year over year.

What was DLB's earnings growth in the past year?

As of Dolby Laboratories's earnings date in Invalid Date, Dolby Laboratories's earnings has grown 34.17% year over year. This is 28.09 percentage points higher than the US Specialty Business Services industry earnings growth rate of 6.08%. DLB earnings in the past year totalled $256.63 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.